Reactive oxygen species in tumor progression, Front Biosci, vol.10, pp.1881-96, 2005. ,
Reactive oxygen species: role in the development of cancer and various chronic conditions, J Carcinog, vol.5, p.14, 2006. ,
Aiding and abetting roles of NOX oxidases in cellular transformation, Nat Rev Cancer, vol.12, pp.627-664, 2012. ,
NADPH oxidases NOXs and DUPXs as putative targets for cancer therapy, Anticancer Agents Med Chem, vol.13, pp.502-516, 2013. ,
Reactive oxygen species: from health to disease, Swiss Med Wkly, vol.142, p.13659, 2012. ,
ROS, stress-activated kinases and stress signaling in cancer, EMBO Rep, vol.3, pp.420-425, 2002. ,
Redox regulation of cancer cell migration and invasion, Mitochondrion, vol.13, pp.246-53, 2013. ,
Reactive oxygen species in cell signaling, Am J Physiol Lung Cell Mol Physiol, vol.279, pp.1005-1033, 2000. ,
Toxicity and roles of reactive oxygen species, Curr Drug Targets Inflamm Allergy, vol.4, pp.489-95, 2005. ,
The NOX family of ROS-generating NADPH oxidases: physiology and pathophysiology, Physiol Rev, vol.87, pp.245-313, 2007. ,
Estrogen receptor-mediated regulation of oxidative stress and DNA damage in breast cancer, Carcinogenesis, vol.25, pp.3-9, 2004. ,
Effect of estradiol and selected antiestrogens on pro-and antioxidant pathways in mammalian uterus, Contraception, vol.60, pp.111-119, 1999. ,
17beta-oestradiol up-regulates longevity-related, antioxidant enzyme expression via the ERK1 and ERK2[MAPK]/ NFkappaB cascade, Aging Cell, vol.4, pp.113-121, 2005. ,
Tamoxifen regulates cell fate through mitochondrial estrogen receptor beta in breast cancer, Oncogene, vol.32, pp.3274-85, 2013. ,
Antihormones in prevention and treatment of breast cancer, Ann N Y Acad Sci, vol.1089, pp.143-58, 2006. ,
Tamoxifen resistance and epigenetic modifications in breast cancer cell lines, Curr Med Chem, vol.14, pp.3035-3080, 2007. ,
URL : https://hal.archives-ouvertes.fr/inserm-00230236
Cellular and molecular pharmacology of antiestrogen action and resistance, Pharmacol Rev, vol.53, pp.25-71, 2001. ,
Acid-degradable coreshell nanoparticles for reversed tamoxifen-resistance in breast cancer by silencing manganese superoxide dismutase (MnSOD), Biomaterials, vol.34, pp.10228-10265, 2013. ,
Long-term treatment with the pure anti-estrogen fulvestrant durably remodels estrogen signaling in BG-1 ovarian cancer cells, J Steroid Biochem Mol Biol, vol.132, pp.692-700, 2012. ,
URL : https://hal.archives-ouvertes.fr/inserm-00705893
Fulvestrant-a novel endocrine therapy for breast cancer, Curr Med Chem, vol.17, pp.902-916, 2010. ,
Fulvestrant: a review of its use in the management of hormone receptor-positive metastatic breast cancer in postmenopausal women, Drugs, vol.71, pp.363-80, 2011. ,
Redox regulation of cell survival, Antioxid Redox Signal, vol.10, pp.1343-74, 2008. ,
Hydroxytamoxifen induces a rapid and irreversible inactivation of an estrogenic response in an MCF-7-derived cell line, Cancer Res, vol.54, pp.5860-5866, 1994. ,
Involvement of HP1alpha protein in irreversible transcriptional inactivation by antiestrogens in breast cancer cells, FEBS Lett, vol.579, pp.4278-86, 2005. ,
URL : https://hal.archives-ouvertes.fr/hal-00016567
Re´gulation de l'activite´ des NADPH oxydases en pre´sence d'acides gras, Ann Biol Clin, vol.65, pp.33-40, 2007. ,
Expression of NADPH oxidase homologues and accessory genes in human cancer cell lines, tumours and adjacent normal tissues, Free Radic Res, vol.43, pp.523-555, 2009. ,
The nitroxide Tempol modulates anthracycline resistance in breast cancer cells, Free Radic Biol Med, vol.40, pp.1409-1427, 2006. ,
Progesterone antagonizes the vasoprotective effect of estrogen on antioxidant enzyme expression and function, Circ Res, vol.97, pp.1046-54, 2005. ,
17beta-estradiol inhibition of NADPH oxidase expression in human endothelial cells, Faseb J, vol.15, pp.2121-2151, 2001. ,
The NADPHoxidase subunit p22phox inhibits the function of the tumor suppressor protein tuberin, Am J Pathol, vol.176, pp.2447-55, 2010. ,
NADPH oxidase activation in pancreatic cancer cells is mediated through Akt-dependent up-regulation of p22phox, J Biol Chem, vol.286, pp.7779-87, 2011. ,
Diphenyleneiodonium induces ROS-independent p53 expression and apoptosis in human RPE cells, FEBS Lett, vol.581, pp.180-186, 2007. ,
The NADPH oxidase inhibitor apocynin (acetovanillone) induces oxidative stress, Toxicol Appl Pharmacol, vol.212, pp.179-87, 2006. ,
, Breast Cancer, vol.23, pp.692-700, 2016.